These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30845956)

  • 21. Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.
    Wang Z; Wang Z; Wang T; Yuan J; Wang X; Zhang Z
    Rev Cardiovasc Med; 2019 Sep; 20(3):187-197. PubMed ID: 31601093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol treatment promotes cardiac stem cell (CSC)-derived growth factors, thus improving CSC-mediated cardioprotection after acute ischemia/reperfusion.
    Wang L; Gu H; Turrentine M; Wang M
    Surgery; 2014 Aug; 156(2):243-52. PubMed ID: 24957669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterned Arteriole-Scale Vessels Enhance Engraftment, Perfusion, and Vessel Branching Hierarchy of Engineered Human Myocardium for Heart Regeneration.
    Kant RJ; Dwyer KD; Lee JH; Polucha C; Kobayashi M; Pyon S; Soepriatna AH; Lee J; Coulombe KLK
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
    Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
    Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion.
    Huang C; Gu H; Yu Q; Manukyan MC; Poynter JA; Wang M
    PLoS One; 2011; 6(12):e29246. PubMed ID: 22195033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
    Redd MA; Scheuer SE; Saez NJ; Yoshikawa Y; Chiu HS; Gao L; Hicks M; Villanueva JE; Joshi Y; Chow CY; Cuellar-Partida G; Peart JN; See Hoe LE; Chen X; Sun Y; Suen JY; Hatch RJ; Rollo B; Xia D; Alzubaidi MAH; Maljevic S; Quaife-Ryan GA; Hudson JE; Porrello ER; White MY; Cordwell SJ; Fraser JF; Petrou S; Reichelt ME; Thomas WG; King GF; Macdonald PS; Palpant NJ
    Circulation; 2021 Sep; 144(12):947-960. PubMed ID: 34264749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Cardiac Progenitor Cell-Derived Extracellular Vesicles Exhibit Promising Potential for Supporting Cardiac Repair
    Romano V; Belviso I; Sacco AM; Cozzolino D; Nurzynska D; Amarelli C; Maiello C; Sirico F; Di Meglio F; Castaldo C
    Front Physiol; 2022; 13():879046. PubMed ID: 35669580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
    Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
    Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empowering human cardiac progenitor cells by P2Y
    Khalafalla FG; Kayani W; Kassab A; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Norman B; Dembitsky WP; Sussman MA
    J Physiol; 2017 Dec; 595(23):7135-7148. PubMed ID: 28980705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Model of Blood Component-Heart Interaction in Cardiac Ischemia-Reperfusion Injury using a Langendorff-Based Ex Vivo Assay.
    Muessig JM; Kaya S; Moellhoff L; Noelle J; Hidalgo Pareja L; Masyuk M; Gerdes N; Pernow J; Kelm M; Jung C
    J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):164-173. PubMed ID: 31495204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pulmonary microvasculature entraps induced vascular progenitor cells (iVPCs) systemically delivered after cardiac ischemia-reperfusion injury: Indication for preservation of heart function via paracrine effects beyond engraftment.
    Ziegler M; Haigh K; Nguyen T; Wang X; Lim B; Yap ML; Eddy EM; Haigh JJ; Peter K
    Microcirculation; 2019 Feb; 26(2):e12493. PubMed ID: 30030876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
    Balbi C; Lodder K; Costa A; Moimas S; Moccia F; van Herwaarden T; Rosti V; Campagnoli F; Palmeri A; De Biasio P; Santini F; Giacca M; Goumans MJ; Barile L; Smits AM; Bollini S
    Int J Cardiol; 2019 Jul; 287():87-95. PubMed ID: 30987834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia Prevents Mitochondrial Dysfunction and Senescence in Human c-Kit
    Korski KI; Kubli DA; Wang BJ; Khalafalla FG; Monsanto MM; Firouzi F; Echeagaray OH; Kim T; Adamson RM; Dembitsky WP; Gustafsson ÅB; Sussman MA
    Stem Cells; 2019 Apr; 37(4):555-567. PubMed ID: 30629785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro expansion of human cardiac progenitor cells: exploring 'omics tools for characterization of cell-based allogeneic products.
    Gomes-Alves P; Serra M; Brito C; Ricardo CP; Cunha R; Sousa MF; Sanchez B; Bernad A; Carrondo MJ; Rodriguez-Borlado L; Alves PM
    Transl Res; 2016 May; 171():96-110.e1-3. PubMed ID: 26924043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury.
    Kongpol K; Nernpermpisooth N; Prompunt E; Kumphune S
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31683729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotrophin-3 contributes to benefits of human embryonic stem cell-derived cardiovascular progenitor cells against reperfused myocardial infarction.
    Bi W; Wang J; Jiang Y; Li Q; Wang S; Liu M; Liu Q; Li F; Paul C; Wang Y; Yang HT
    Stem Cells Transl Med; 2021 May; 10(5):756-772. PubMed ID: 33529481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditioned medium from adipose-derived stem cells attenuates ischemia/reperfusion-induced cardiac injury through the microRNA-221/222/PUMA/ETS-1 pathway.
    Lee TL; Lai TC; Lin SR; Lin SW; Chen YC; Pu CM; Lee IT; Tsai JS; Lee CW; Chen YL
    Theranostics; 2021; 11(7):3131-3149. PubMed ID: 33537078
    [No Abstract]   [Full Text] [Related]  

  • 39. Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.
    Intachai K; C Chattipakorn S; Chattipakorn N; Shinlapawittayatorn K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis.
    Yang J; Tang L; Zhang F; Yang T; Lu T; Sun K; Sun N; Ren J; Yan M
    Stem Cell Res Ther; 2021 Nov; 12(1):584. PubMed ID: 34809715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.